LAS VEGAS—Innovative programs have enhanced responses to drug diversion at several large health systems across the United States by focusing on staffwide education, surveillance software and other improvements, according to speakers at the ASHP 2022 Midyear Clinical Meeting & Exhibition.
“You don’t have to wait for a catalyst event to make drug diversion a patient safety initiative,” said Mary Nelson, MSN, RN, CPPS, the drug diversion